# Safety/Tolerability and Efficacy of YHD001 in Patients With Acute and Chronic Bronchitis

> **NCT01420445** · PHASE2 · COMPLETED · sponsor: **Yuhan Corporation** · enrollment: 118 (actual)

## Conditions studied

- Acute Bronchitis
- Chronic Bronchitis

## Interventions

- **DRUG:** YHD001 dose level 1
- **DRUG:** YHD001 dose level 2
- **DRUG:** Pelargonium sidoides extract
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01420445
- **Lead sponsor:** Yuhan Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2012-05
- **Final completion:** 2012-05
- **Target enrollment:** 118 (ACTUAL)
- **Last updated:** 2013-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01420445

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01420445, "Safety/Tolerability and Efficacy of YHD001 in Patients With Acute and Chronic Bronchitis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01420445. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*